New 2026 Study: Chitosan Was Linked to Lower Blood Microplastic Levels in Humans
Share
TL;DR:
- A new 2026 chitosan microplastics study followed 21 healthy adults and measured microplastics in blood.
- Participants taking PCC-chitosan for 15 days showed a reported 26.3% mean reduction in circulating microplastic concentration, while the placebo group did not show a significant change.
- The study is small and preliminary, so it should be read as early human evidence—not proof of guaranteed results.
- The findings support the same broad strategy behind Sifts: helping the digestive tract manage microplastic exposure through binding and normal elimination pathways.
For years, the microplastics conversation has focused on exposure: plastic particles in food, water, air, and packaging. The harder question has been what happens after those particles enter the body. A new pilot-controlled study published in Journal of Xenobiotics adds an important data point: researchers reported lower circulating microplastic levels after 15 days of PCC-chitosan supplementation in healthy adults.[1]
This matters because microplastics have already been measured in human blood. A 2022 Environment International study reported plastic particles in whole blood from healthy volunteers, and a 2024 follow-up study identified multiple polymer types in human blood samples using µFTIR methods.[2] [3] The new question is no longer only “are we exposed?” It is also “can the digestive tract help reduce internal burden?”
What the 2026 Chitosan Microplastics Study Tested
The study evaluated whether oral PCC-chitosan, a chitosan derived from Procambarus clarkii, could reduce circulating microplastics through what the authors describe as gastrointestinal sequestration. In simpler terms, the proposed mechanism is that chitosan may form networks in the gut that help trap microplastic particles and support their movement out through normal digestive elimination.
| Study detail | What researchers reported |
|---|---|
| Participants | 11 adults in the PCC-chitosan group and 10 matched controls in the placebo group |
| Dose and duration | 0.8 g/day of PCC-chitosan for 15 days |
| Measurement methods | Stereomicroscopy, scanning electron microscopy, and micro-Fourier transform infrared spectroscopy |
| Baseline finding | Microplastics were found in every subject at baseline |
| Main result | Mean blood microplastic concentration decreased from 1.84 ± 0.28 µg/mL to 1.34 ± 0.20 µg/mL in the PCC group, a reported 26.3% reduction |
| Control group | No significant difference was observed |
| Key limitation | Pilot-sized study; larger, longer, independently replicated trials are still needed |
Why Chitosan Is Getting Attention
Chitosan is a non-digestible dietary fiber produced from chitin. In the microplastics literature, interest in chitosan has grown because early studies suggest it may help bind or carry particles through the digestive tract. A 2025 human stool study found that PCC-chitosan was associated with increased fecal excretion of several microplastic types after a standardized meal, while a 2025 Scientific Reports rat study found that chitosan increased fecal excretion and reduced intestinal retention of polyethylene microplastics.[4] [5]
The 2026 blood study is different because it looked at circulating microplastics, not only stool excretion. That makes it especially relevant for health-optimization readers tracking the shift from “avoid exposure” to “support elimination.” Still, the correct interpretation is careful: this is promising early evidence, not a final answer.
How This Connects to Sifts
Sifts was built around a practical idea: reducing exposure matters, but daily support inside the digestive tract may matter too. Sifts includes clinically studied ingredients selected to support binding in the gut and normal digestive elimination. The product is not a substitute for reducing plastic exposure, but it can fit into a broader routine that includes cleaner food storage, filtered water, less plastic heat contact, and better awareness of hidden microplastic sources.
If you want the deeper scientific rationale behind the formula, review the Sifts science page. For related context, Sifts has also covered microplastics and gut health and how microplastic exposure may intersect with cellular aging.
What Not to Overread
The study is promising, but still early. It was small, short, and microplastic measurement remains technically complex. The key takeaway: Chitosan may support gut-based microplastic elimination, but larger studies are needed.
For now, the best approach is layered: reduce avoidable plastic exposure, support the gut, and follow the evidence as it develops.
FAQ
What did the 2026 chitosan microplastics study find?
The study reported that healthy adults taking 0.8 g/day of PCC-chitosan for 15 days had a 26.3% mean reduction in circulating blood microplastic concentration, while matched placebo controls did not show a significant change. Because the study was small, the finding should be viewed as preliminary.
Does chitosan remove microplastics from the body?
Current research suggests chitosan may help bind certain microplastic particles in the digestive tract and support fecal elimination. However, the evidence is still early, and no supplement should be described as guaranteed to remove microplastics from the body.
How does Sifts Daily fit into a microplastic-reduction routine?
Sifts Daily is designed to support the body’s natural digestive pathways for managing microplastic exposure. It fits best alongside exposure-reduction habits such as avoiding heating food in plastic, choosing lower-plastic kitchen materials, and improving water filtration.
Disclaimer: The information in this article is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition, including prostate health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.